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MODELING TRAUMATIC BRAIN INJURY: MECHANISMS OF EARLY 
NEURONAL AND AXON DEGENERATION IN THE INFANT RODENT BRAIN
Krikor Dikranian 
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Traumatic brain injury (TBI) remains a major health challenge and affects the young disproportionately. Accidental and non-
accidental TBI in children is a major contributor to morbidity, disability, and death. TBI in this critical period leads to profound 
neuronal and axonal degeneration followed by cognitive, psychological and memory impairment, altered processing speed, 
impaired executive functions, emotional liability as well as word finding difficulties. Cognitive and behavioral changes may 
remain unrecognized for periods even after sustaining mild injury. Although accidental and non-accidental inflicted injury (blunt 
force or violent shaking-inflicting brain injury or “Shaken baby” syndrome) posits a major clinical and sociological problem, 
mechanisms of tissue degeneration might be largely similar. The scope of this review will be the experimental research related 
to modeling blunt (concussive) head trauma specifically to the infant rodent brain resulting in acute (early) and protracted (late) 
degenerative changes such as axonal degeneration and apoptotic neuronal cell death. Similarly, discussion will be limited to 
therapeutic windows and potentials for ameliorating the development of early brain injury. Biomed Rev 2019;30:25-36
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R e v i e w
INTRODUCTION
While accidental TBI has been recognized for hundreds of 
years, the history of reporting non-accidental brain trauma 
begins in 1860 by the publication of an article by the French 
physician, Ambroise Tardieu, describing 32 cases of physical 
abuse (61). Later, in 1946 John Caffey reported cases with 
subdural hematomas in six children (61). Finally, many 
years later, a publication in 1962 named “The battered child 
syndrome” made history by leading to the creation of laws 
protecting children in the USA including the reporting of 
child maltreatment (45). Importantly, following legislations 
have also sparked the interest and attention of the medical 
and academic communities in studying the pathophysiological 
mechanisms of all TBIs as well as their diagnosis and treatment 
options. More than half a million children (around 600 000 
as reported in 2012) sustain TBI and are hospitalized in the 
USA alone. Of these 300 000 are from contact sports alone. 
More than 50000 of hospitalizations end up with disabilities, 
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of them about 10% need intensive inpatient care and 
rehabilitation. Annually there are 7400 deaths with fatality 
rate between  30.5% and 35.7% (3, 74).  Children under six 
years of age sustain traumatic brain injury more frequently 
than any other age group (2, 3). From all pediatric head trauma 
hospitalizations, 11.6% were infants below the age of 1 year. 
According to the recent literature there are two large peaks in 
pediatric	TBI	and	the	first	one	is	in	early	childhood	–	0	to	4	
years (74).  The infant is highly susceptible to head trauma and 
brain injury is the most important outcome of head contusion 
(3, 25, 30, 31, 32, 35, 57). A study in 1995 has found that in 
a cohort of children suffering severe head injury prior to the 
age of 4 years none was able to work independently outside a 
structured environment years later, whereas children older than 
4 years at the time of injury had a better outcome (48, 74, 75). 
Recent developments in clinical trials for the treatment of TBI 
lead to the following conclusions: in many cases “mild” brain 
injury is never really mild, functional deficits may appear 
long after the initial injury and post-injury structural and 
functional reorganization may not always be adaptive. 
Importantly no neuroprotective agents are clinically available. 
The search for safe and effective therapy especially for the 
acute phase of TBI so far has been disappointing (74, 78). 
CRITICAL PERIODS OF BRAIN DEVELOPMENT
During human brain development there are periods of 
time-sensitive sequential events that are critical to normal 
brain function in adult life. According to most studies, the 
neurogenesis and migration of neuroblasts starts at the 
embryonal age of 6 weeks, the incidences of programmed cell 
death starts at embryonal age of 24 months, while gliogenesis 
continues well after birth and in some cases around the 
postnatal age of 24 (71). Importantly, during the last trimester 
of	fetal	life	and	the	first	2	years	of childhood, the human brain 
undergoes a period of rapid growth termed the “brain growth 
spurt” (10, 39, 47, 54). It is characterized by a number of 
neurodevelopmental changes, including pronounced dendritic 
and axonal outgrowth, establishment of neural connections 
and circuits via intense synaptogenesis paralleled by synapse 
elimination (22, 23, 49, 71). In the rodent the “brain growth 
spurt”	 is	shifted	postnatally	 into	 the	first	 two	weeks	of	 life	
(5, 8, 34, 81).
MODELS OF TBI
Several well established impact models are historically  used 
to study TBI-induced neurodegeneration in immature (P3 
and P21) rodents  (1, 6, 11, 13, 14, 15, 20, 40, 42,  63, 65). 
They correspond to infant and toddler age in humans (66, 82). 
Among these trauma models, three have been most widely 
used:	 the	weight	 drop	model	 (30,	 41),	 the	fluid	percussion	
model (54) and the controlled cortical impact model (21, 40) 
The	fluid	percussion	model	produces	brain	 injury	by	 rapid	
injection of small volumes of saline into a closed cranial 
cavity against the dura mater (2, 63). The weight drop model 
was	modified	by	Marmarou	et al. (1994) to a closed head 
injury model (55). Our group used initially the weight drop 
model in an attempt to model infant TBI (41). To further 
study developmental TBI more precisely, a novel impact 
system was developed in 2006 at Washington University in 
Saint	Louis	to	deliver	a	controlled	impact	to	the	flexible	skull	
of an infant rodent (7 - 10 days postnatally). This system 
uses an electromagnetic actuator mounted on a stereotaxic 
instrument	(Fig.	1)	to	impact	the	exposed	skull	at	a	specified	
angle, velocity and depth (6, 7, 20). The device was intended 
to produce injury similar to that achieved with a weight-drop 
device	(12,	41)	but	with	improved	precision	and	flexibility.	
With this device it was possible to consistently deliver 
impacts of comparable depth and injury characteristics, and 
at the same time determine whether the impact and injury 
was mild, moderate or severe depending on physiological 
manifestation, skull fracture, hemorrhage an tissue changes. 
Using similar device it was also possible to study mechanical 
strain associated with the impact. This method calculates 
maximum principal strain using tagged magnetic resonance 
imaging (MRI) of the brain during indentation of the skull and 
provides both qualitative and quantitative assessment of the 
mechanical insult to the tissue (6, 7). All traumatic brain injury 
models cause a rapid deformation of the cortical surface. This 
component of the tissue reaction entails direct tensile injury 
to nerve cell bodies and their white matter axons and appears 
to be the way developing nerve cell bodies and axons respond 
to	rapid	deformation.	Any	fiber	tract	passing	through	a	portion	
of the impact zone where strains are high will be subjected to 
stretch injury (6, 7).
EFFECT OF TBI ON THE INFANT BRAIN: EARLY EXCITOTOXIC 
NEURONAL CELL DEGENERATION.
TBI to P3-P14 rodents has resulted in neuronal cell death 
which peaked relatively early, 24 hours post-injury. The initial 
trauma-induced cell degeneration is excitotoxic in nature (78) 
and occurs under the area of impact (a.k.a. penumbra area) 
(Fig. 2). This component of tissue reaction entails direct 
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Figure 1. A. Image of the stereotaxic instrument with the electromagnetic actuator. B. Close up image showing the metal tip of 
the impactor (*) and the plastic molded head side support device (arrows).
Figure 2. Penumbra area, plastic section (A) and diagram (B). Inset in A the shows development of excitotoxic neuronal changes 
(from left to right – one normal and two degenerating neurons).
tensile injury to nerve cell bodies and their axons and appears 
to be the way developing nerve cell bodies respond to rapid 
deformation. This is accompanied by early (within 30 min) 
axonal swellings detected in the cingulum and external capsule, 
two white matter brain structures which sustain rapid tensile 
forces during impact (6, 7). The excitotoxic reaction kills 
affected neurons very rapidly - within 2 hours post impact. 
(6, 11, 12, 13, 24, 20, 29). This type of cell degeneration has 
distinct features which were best evaluated by reviewing 1 
mm plastic sections stained with toluidine blue and further 
examined with electron microscopy - the gold standard for 
evaluating excitotoxicity (42). Initially, neuronal cell bodies 
undergo extreme edematous swelling which is accompanied by 
degeneration	of	mitochondria.	Specific	nuclear	changes	begin	
by the formation of small aggregates of clumped chromatin 
which	give	the	nucleus	a	floccular	appearance	(Fig.	2).	These	
small clumps migrate to the perimeter of the nucleus in a 
clock-face pattern, then coalesce into progressively larger 
clumps and dense mass at the center of the nucleus. The 
nuclear membrane remains relatively intact but the plasma 
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membrane becomes ruptured and loses its integrity early in 
the degenerative process. The release and accumulation of 
potentially damaging factors in the penumbra, such as calcium, 
excitatory amino acids neurotransmitters such as glutamate 
with	 subsequent	 activation	 of	 their	 specific	 receptors,	 are	
considered to be initiators of this type of damage (11, 27). 
Interestingly, after mild trauma to the P7 mouse we did not 
observe any ultrastructural morphological features consistent 
with excitotoxic cell degeneration in the early post-trauma 
period.	Instead,	we	detected	the	first	signs	of	apoptotic	cell	
death.	Clinically,	excitotoxicity	also	plays	a	significant	role	in	
the pathogenesis of TBI in the neonate (71). In adult animal 
TBI studies mild trauma to the exposed skull has not produced 
similar effects (9) which suggest that excitotoxic injury can 
be unique mechanism of early cell degeneration in the infant 
brain.
EFFECT OF TBI ON THE INFANT BRAIN: EARLY AXONAL 
DEGENERATION AND DISRUPTION
The other component to the acute brain tissue reaction is the 
axonal	fiber	tract	component	-	the	underlying	white	matter.	
Previous studies have shown that TBI in the infant and toddler 
rodents	causes	axonal	degeneration	during	the	first	week	post-
injury (3, 40).  Early axonal injury to axons in the cingulum, 
external capsule, corpus callosum has been detected as early 
as 6 hours post trauma (67). However, the very early onset 
and progression of axonal injury (earlier that 4 hours post 
injury) has not been followed until 2008. In our mouse study 
we used a progeny of mThy1-YFP16 line overexpressing 
yellow	fluorescent	protein	in	neurons	and	axons	(28)	which	in	
our hands became an excellent tool to evaluate temporal and 
morphological changes as well as the topography and spread 
of tissue injury (Fig. 3, 4, 5) even without the application of 
specific	immunostaining	methods	used	for	revealing	axonal	
injury such as APP expression (20, 24, 32, 33, 40). Our analysis 
of YFP-expressing transgenic mice showed that the cingulum 
bundle, corpus callosum external and internal capsule are the 
most vulnerable white matter tracts under conditions of mild to 
moderate/severe head trauma (Fig. 3). Importantly, our detailed 
structural and morphometric study of degenerating axonal 
profiles	 in	 the	cingulum/external	capsule	also	 revealed	 that	
axonal injury, even after a mild insult, occurs surprisingly early 
(20) within 30 min post impact and progresses rapidly within 
5 to 24 hours post trauma (Fig. 4).  Injured axons undergo 
rapid and progressive morphological alterations. Initially 
seen as punctate spots in YFP-only (non-stained) and in APP 
immunolabeled sections (Fig 4A, C, and D), YFP positive 
and APP positive segments along each axonal axis became 
longer and thicker within 5 hours post-injury, and ended in 
larger spheroids or clubs-like swellings by 16 hours post 
Figure 3. A- C - mouse cranio-caudal brain levels at which white matter axonal degeneration has been observed after mild to 
moderate/severe brain injury following skull impact.
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Figure 5. Axonal degeneration 15 hous after moderate/
severe trauma.  Diagram in A shows the areas of axonal 
degeneration. B and C (YFP only) show axonal degeneration 
in the ipsilateral (C) as well as in the contralateral external 
capsule (B). G and H - internal capsule, degenerating axons 
observed as spheroids only in the trauma side (E).
Figure 4. Axonal degeneration 30 min. 
and 16 hours post trauma.  A, C and 
D show early degeneration of axons 
in the cingulum/external capsule. 
Degenerating axonal profiles show 
punctate labeling both in unstained 
sections of YFP animals (A) as well 
as in sections labeled for APP (C). 
Many of these positive segments in 
D show double labeling (YFP/ APP) 
characteristics. B shows the brain 
area exhibiting early signs of axonal 
degeneration. E-G Axonal degeneration 
in the external capsule 16 hours post 
trauma. E is the contralateral external 
capsule. F is the trauma side. Note YFP 
positive axonal bulbs and segments at 
this time point post trauma.
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trauma (Fig. 4F) (20). Moderate to heavy trauma expanded the 
territory of axonal degenerations involving contralateral and 
deeper ipsilateral white matter tracts such as the contraleteral 
external capsule and the ipsilateral internal capsule (Fig. 5). 
Our electron microscopic studies showed axoplasmic organelle 
compaction in the spheroids suggesting that axonal transport 
might be impaired in these segments (6, 20). Similar studies 
implicating axonal disruption were made in adult animals (26, 
44) and were associated with axonal disconnection. 
Axonal	 fibers	 tracts	 in	 the	 underlying	white	matter	 in	
neonatal animals are fragile, they course and anchor at certain 
points, which determines how far they can stretch without 
tearing or exceeding injury thresholds.  It is important also 
to consider that the  axons in these white matter tracts in the 
immature rodents are still unmyelinated and can be more 
susceptible to mechanical strain and injury (68). A substantial 
mechanical strain and rapid tissue deformation is experienced 
by these tracts even after mild impact (6, 7, 20). Computational 
studies have shown that for identical cortical displacement, 
the neonatal brain may be under larger peak stress magnitude 
compared to the mature brain due to smaller size and stiffer 
tissue properties (50). The fact that the internal capsule shows 
marked degeneration in axons, which is not seen after mild 
trauma,	signifies	that	more	severe	trauma	causes	higher	white	
matter stress upon impact.
EFFECT OF TBI ON THE INFANT BRAIN: MASSIVE APOPTOTIC 
NEURONAL CELL DEATH
Apoptotic cell death was highest in 3 and 7 day old rats and 
decreased	 significantly	with	 increasing	 age.	By	 the	 time	
excitotoxic neuronal degeneration has run its course within 
several hours post impact, apoptotic cell death in neurons 
takes over. Apoptosis is detectable over a longer time period, 
extending from 4 h to 48 hours post mild trauma (Fig. 6) (20) 
and up to 5 days after more severe TBI. Apoptotic cell death is 
disproportionally greater than excitotoxic neurodegeneration 
and displays a diffuse pattern affecting several brain regions 
(6, 10, 11, 12, 13, 20) depending on the severity of impact. 
The highest densities of apoptotic cells (mostly neurons) fol-
lowing trauma were detected in areas also displaying highest 
densities of physiologic or programmed death (12, 13, 14). 
This may indicate that neurons (and possibly glia) may be 
most vulnerable to apoptosis when exposed to an exogenous 
insult during a certain vulnerable period of their maturation. 
Figure 6. Apoptotic cell degeneration 15 
hours post moderate trauma. A is a light 
microscopic image of Caspase 3 staining 
in the cingulate cortex and thalamus, B is 
a fluorescent microscopy image in a YFP 
animal stained for Caspase 3. Apoptotic 
cell degeneration is seen in the superficial 
and deep layers of the cingulate cortex. 
C shows the topography of Caspase 3 
positive apoptotic cell death in the cortex, 
hippocampus, habenula and thalamus.
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In the case of mild and moderate TBI the early apoptotic 
injury within the cingulate cortex was followed by apoptotic 
cell	death	affecting	specifically	the	anterior	thalamic	nucleus	
which establishes bidirectional anatomic connections with 
the cingulate cortex and thalamocortical and corticothalamic 
projections pass through the cingulum/external capsule (62, 
72). Various studies have shown that normal function and 
survival of neurons in the developing brain is also maintained 
via proper synaptic connection and activity, and in many in-
stances by synaptic activity dependent trophic support between 
projecting neurons and target cells (16).  Loss of synaptic 
connections in the developing brain can cause nerve cells to 
commit suicide. It is therefore possible that communications 
between these areas will be disrupted either by cell death and/
or axonal damage. Loss of synaptic connections between part-
nering neuronal groups may potentially trigger a second way 
of apoptosis at close and distant brain regions.  For example 
experimental target deprivation (visual cortex ablation) in 
infant animals has resulted in neuronal apoptosis in the lateral 
geniculate nucleus (58). Potential involvement of disconnec-
tion mechanisms after TBI has been discussed also by others 
(18).  It is possible, therefore, that during the synaptogenesis 
period, head trauma has the potential to enhance physiological 
cell suicide mechanisms in the brain in multiple ways and kill 
millions of neurons.
POTENTIAL STRATEGIES FOR NEUROPROTECTION 
Anti-excitotoxic therapies 
NMDA antagonists which block the effect of excitotoxicity 
such as ketamine have been used in clinical practice (36, 37). 
Experimental evidence from infant rodents has shown that 
while similar NMDA antagonists are capable of protecting 
early excitotoxic cell degeneration, they have caused an in-
crease in apoptotic cell death (64) which renders this approach 
impractical in the current form. Further studies are needed to 
address pharmacological treatment of early post-traumatic 
excitotoxic neurodegeneration in infant models of TBI (see 
also Bittigau et al.,1998 for extensive discussion on potential 
protective strategies).
Axonal injury and disconnection therapies
Given the rapid development of axonal degeneration in the in-
fant brain following mild TBI, two potential clinically relevant 
questions	need	to	be	asked.	The	first	is,	is	there	a	non-invasive	
clinical diagnostic tool by which we can map the territory and 
extent of axonal injury? In the past decade diffusion tensor 
imaging (DTI) has emerged as a reliable tool to register axonal 
injury both in rodent models of TBI as well as in the clinic (51, 
52, 80). Results from the clinic suggest that DTI measures such 
as reduced anisotropy are sensitive but are discussed as long-
term changes correlated to posttraumatic clinical evaluations 
in children (80). Our results in adult mice showed that both 
histological markers of TBI such as APP immunolabeling as 
well as certain DTI parameters (reduced axial diffusivity and 
relative anisotropy) were positively correlated in the extent 
of axonal injury in the pericontusion zone following moder-
ate to severe trauma to the exposed skull. In an experimental 
TBI study of repetitive (two impacts within 24) moderate 
skull	 impact	 to	adult	mice	observed	no	significant	changes	
in	DTI	measurements	compared	to	controls	(9).	Significant	
decrease in axial diffusivity was registered after seven days 
following trauma. These experimental studies suggest that at 
least in moderate to severe head trauma animal models DTI 
may be a reliable marker for identifying early axonal injury 
and disconnection.
The second clinically relevant question is, given the 
early occurrence of axonal injury even in mild TBI, is there 
a therapeutic window for the use of drugs to ameliorate 
axonal swelling and disconnections? Several studies have 
shown that targeting mitochondria damage and preserving 
cellular energy homeostasis by cyclosporin A (CsA), a 
potent inhibitor of Ca2+-induced mitochondrial damage, 
administered intrathecally 30 min prior to traumatic brain 
injury, preserved mitochondrial integrity, significantly	reduced	
spectrin	 proteolysis	 and	 neurofilament	 compaction	 and	
attenuated axonal degeneration. (15, 59, 60, 73). These studies 
demonstrate the therapeutic potential of CsA administration in 
the early posttraumatic period to protect axonal disconnection. 
Similar to antiexcitotoxic therapy, further studies will be 
needed to identify the precise molecular mechanisms of axonal 
injury as well as their therapeutic targets.
Antiapoptotic therapies
The	significant	increase	in	apoptotic	cell	death	in	infant	mice	
as revealed by caspase-3 activation and our ultrastructural 
analysis	supports	previous	findings	that	apoptosis	is	a	major	
contributor to early post-traumatic neuronal degeneration in 
the immature brain compared to the more limited, biphasic 
and delayed apoptotic death in adults (18, 83, 84). Apoptotic 
cell death and excitotoxicity similarly play crucial roles in 
the pathogenesis of TBI in the neonate (70, 85). In the clinic 
this phenomenon can potentially contribute to the unfavorable 
developmental outcomes reported in young children but at 
the same time be considered as a potential treatment window 
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for targeted pharmacological treatment aimed at blocking 
mechanisms of apoptotic cell death such as free radical 
scavengers, antioxidants, the TNF inhibitor pentoxifylline and 
others (64, 85). Targeting the downstream effectors of neuronal 
apoptosis (17, 38) in the acute phase post trauma may have 
good therapeutic potential in the immature brain by allowing 
neurons and perhaps other cell types enough time to upregulate 
homeostatic protection systems. On the other hand, preventive 
measures to ameliorate progressive axonal injury and axotomy-
induced deafferentiation, as discussed above, might be equally 
beneficial	 in	preventing	apoptotic	 cell	death	 (see	Felderhof-
Mueser and Ikonomidou, 2000, for an extensive review) (29). 
Although	there	are	several	encouraging	studies	in	the	beneficial	
effect of hypothermia on apoptosis both experimentally and 
clinically (4, 46, 76, 77, 79) further research initiatives must 
evaluate mechanisms of hypothermia induced post TBI-induced 
amelioration of apoptosis in the infant brain.
CONCLUDING REMARKS
At the time this manuscript was in preparation Rivara et al., 
2019 (69) published an important report produced by 11 
experts	in	the	field	of	sport	related	concussions	in	children.	
The panel concluded that “….There is no clear evidence in 
the literature that a specific age or developmental stage in 
children is safer or more appropriate for starting contact 
sports…” and that “…Experiencing multiple concussions in 
youth is one risk factor among many that may be associated 
with more long-lasting symptoms and longer recovery.” The 
consensus statement further elaborated on the limitations of 
both in the quantity and quality of evidence preventing experts 
to issue recommendations to parents and other stake holder 
for practicing in contact sports such as ice hockey and football 
and stated that still there is not enough good quality research 
“to help guide us for making recommendations for families 
about many things about concussions.”. 
It	is	upon	the	scientific	and	clinical	communities	to	continue	
the development of state-of-the-art research on the mechanics, 
mechanism, diagnosis of infant and child TBIs of all severity 
grades, better practical treatment options in the clinic as well 
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